LLK203 | MedChemExpress (MCE)
LLK203 is a potent USP2/USP8 dual-target inhibitor with IC50s of 0.89 μM and 0.52 μM, respectively. LLK203 leads a degradation of ERα and induces apoptosis of breast cancer MCF-7 cells. LLK203 demonstrates antitumor activities against the 4T1 tumor mice model[1].
| Trivial name | LLK203 |
| Catalog Number | HY-162312 |
| Research Area | Cancer |
| CAS# | 2758090-62-7 |
| Purity | ≥98.0% |
| SMILES | O=C(C1=CC=C(OC)C=C1NS(=O)(C2=CC=C(C3=CC=C(C)S3)C=C2)=O)NC4=NC(C5=CC=CC=C5)=CS4 |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/llk203.html |